Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting
Stock Information for Axsome Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.